PolyPid director files initial holdings report

PolyPid Ltd. director Krinsky Itzhak filed an initial ownership report showing a mix of ordinary shares and stock options.

Rhea-AI Filing Summary

PolyPid Ltd. director Krinsky Itzhak filed an initial ownership report showing a mix of ordinary shares and stock options. He directly holds 833 Ordinary Shares. He also holds several stock option awards over Ordinary Shares, including 6,500 shares at an exercise price of $4.2400 expiring on July 2, 2034 and 14,440 shares at $2.6700 expiring on June 25, 2035. Additional options cover smaller amounts of shares at exercise prices of $11.4000 and $23.0700 with expiration dates between 2029 and 2033. Footnotes state that most of these options are already fully vested, while the June 25, 2025 grant vests quarterly until May 12, 2029.

Insider Trade Summary

7 transactions reported

Mixed 7 txns

Insider Krinsky Itzhak

Role Director

Type	Security	Shares	Price	Value
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Stock option (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock option (right to buy) — 22,460 contracts (Direct); Ordinary Shares — 833 shares (Direct)

Footnotes (6)

1. F1. The options were granted on May 5, 2023 and fully vested as of May 5, 2024.
2. F2. The options were granted on August 7, 2019 and fully vested as of January 2, 2022.
3. F3. The options were granted on April 13, 2021 and fully vested as of April 13, 2022.
4. F4. The options were granted on May 3, 2022 and fully vested as of May 3, 2023.
5. F5. The options were granted on July 2, 2024 and fully vested as of July 2, 2025.
6. F6. The options were granted on June 25, 2025 and vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PolyPid (PYPD) director Krinsky Itzhak report in this Form 3?

Krinsky Itzhak reports his initial ownership in PolyPid, including 833 Ordinary Shares and multiple stock option awards. The options cover different numbers of Ordinary Shares at various exercise prices and expiration dates, with most already fully vested according to the footnotes.

How many PolyPid (PYPD) Ordinary Shares does Krinsky Itzhak hold directly?

He directly holds 833 Ordinary Shares. This figure reflects his non-derivative ownership separate from options. In addition, he holds several stock option grants over PolyPid Ordinary Shares, which could be exercised in the future according to their terms and vesting schedules.

What are the largest stock option positions reported by Krinsky Itzhak in PYPD?

The largest option positions are for 14,440 Ordinary Shares at an exercise price of $2.6700 expiring on June 25, 2035, and 6,500 Ordinary Shares at $4.2400 expiring on July 2, 2034. Both are held directly and relate to previously granted awards.

Are Krinsky Itzhak’s PolyPid (PYPD) stock options vested?

Footnotes state that options granted on May 5, 2023; August 7, 2019; April 13, 2021; May 3, 2022; and July 2, 2024 are fully vested. Options granted on June 25, 2025 vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

Does this PolyPid (PYPD) Form 3 show any insider buying or selling?

No specific purchases or sales are shown. The entries are labeled as holdings, with transaction direction marked as unknown and no buy or sell codes. The filing mainly lists existing Ordinary Share and stock option positions for director Krinsky Itzhak.

What are the exercise prices and expirations of Krinsky Itzhak’s other PYPD options?

Additional options cover 312 Ordinary Shares at $11.4000 expiring on May 5, 2033, plus 597, 299 and 312 shares at $23.0700 expiring on August 7, 2029, April 13, 2031, and May 3, 2032, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Krinsky Itzhak

(Last) (First) (Middle)

C/O POLYPID LTD.

18 HASIVIM STREET ISRAEL

(Street)

PETACH TIKVA 495376

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	833	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	08/05/2023	05/05/2033	Ordinary Shares	312(1)	$11.4	D
Stock option (right to buy)	01/02/2020	08/07/2029	Ordinary Shares	597(2)	$23.07	D
Stock option (right to buy)	07/13/2021	04/13/2031	Ordinary Shares	299(3)	$23.07	D
Stock option (right to buy)	08/03/2022	05/03/2032	Ordinary Shares	312(4)	$23.07	D
Stock option (right to buy)	10/02/2024	07/02/2034	Ordinary Shares	6,500(5)	$4.24	D
Stock option (right to buy)	08/12/2025	06/25/2035	Ordinary Shares	14,440(6)	$2.67	D

Explanation of Responses:

1. The options were granted on May 5, 2023 and fully vested as of May 5, 2024.

2. The options were granted on August 7, 2019 and fully vested as of January 2, 2022.

3. The options were granted on April 13, 2021 and fully vested as of April 13, 2022.

4. The options were granted on May 3, 2022 and fully vested as of May 3, 2023.

5. The options were granted on July 2, 2024 and fully vested as of July 2, 2025.

6. The options were granted on June 25, 2025 and vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

	/s/ Itzhak Krinsky	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)